The study is enrolling newborn males up to seven months of age at screening who are diagnosed ... and infectious diseases such as chronic hepatitis B where no adequate treatments exist.

Introduction: Infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is a public health problem ...

3 German Centre for Infection Research (Deutsches Zentrum für Infektionsforschung DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany 4 Computational Biology for Individualised Medicine, ...

Dicerna Pharma has enticed another big pharma to partner its RNA interference platform, attracting a $200 million upfront deal with Roche for a drug to treat hepatitis B virus infections.

Objective Hepatitis B virus (HBV ... from 18 patients with chronic HBV infection. Characteristics of the study population are summarised in online supplemental table S2. Among them, 10 were male and 8 ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...

Vir Bio (VIR) reveals 24-week post-end-of-treatment data from a mid-stage trial for its Hep B therapy developed with Xencor ...

For patients with chronic viral hepatitis ... Researchers in India evaluated 1387 adults with asymptomatic hepatitis B virus (HBV) infection to determine the correlation between liver-enzyme ...

Certain health conditions, such as obesity and AFib, and leading an unhealthy lifestyle can increase the functional age of ...

may shortly become the primary treatment of choice for patients with chronic hepatitis B.

Scientists have developed an A.I. tool that they say can help assess a patient’s health — and potentially guide their medical ...